Cargando…
F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China
INTRODUCTION: Type of F8 gene mutation is the most important risk factor for inhibitor development in people with severe hemophilia A. However, there are few large cohort studies on the F8 mutation spectrum of people with severe hemophilia A with inhibitors. OBJECTIVE: This was the first large cohor...
Autores principales: | Sun, Jie, Li, Zekun, Huang, Kun, Ai, Di, Li, Gang, Xie, Xingjuan, Gu, Hao, Liu, Guoqing, Zhen, Yingzi, Chen, Zhenping, Wu, Runhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175357/ https://www.ncbi.nlm.nih.gov/pubmed/35702590 http://dx.doi.org/10.1002/rth2.12723 |
Ejemplares similares
-
Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes
por: Sun, Jie, et al.
Publicado: (2022) -
Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
por: Chen, Zhenping, et al.
Publicado: (2021) -
Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
por: Liu, Guoqing, et al.
Publicado: (2022) -
F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
por: Liu, Guoqing, et al.
Publicado: (2023) -
Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
por: Li, Zekun, et al.
Publicado: (2021)